[go: up one dir, main page]

SE0303418D0 - New use 1 - Google Patents

New use 1

Info

Publication number
SE0303418D0
SE0303418D0 SE0303418A SE0303418A SE0303418D0 SE 0303418 D0 SE0303418 D0 SE 0303418D0 SE 0303418 A SE0303418 A SE 0303418A SE 0303418 A SE0303418 A SE 0303418A SE 0303418 D0 SE0303418 D0 SE 0303418D0
Authority
SE
Sweden
Prior art keywords
new use
mglur5
ibs
antagonists
treatment
Prior art date
Application number
SE0303418A
Other languages
English (en)
Inventor
Haakan Larsson
Anders Lehmann
Erik Lindstroem
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0303418A priority Critical patent/SE0303418D0/sv
Publication of SE0303418D0 publication Critical patent/SE0303418D0/sv
Priority to US10/582,388 priority patent/US20070203163A1/en
Priority to CNA2004800366703A priority patent/CN1897943A/zh
Priority to JP2006545735A priority patent/JP2007514788A/ja
Priority to PCT/US2004/041005 priority patent/WO2005060965A1/en
Priority to EP04813335A priority patent/EP1694326A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE0303418A 2003-12-17 2003-12-17 New use 1 SE0303418D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0303418A SE0303418D0 (sv) 2003-12-17 2003-12-17 New use 1
US10/582,388 US20070203163A1 (en) 2003-12-17 2004-12-08 Novel Treatment Of Irritable Bowel Syndrome 1
CNA2004800366703A CN1897943A (zh) 2003-12-17 2004-12-08 肠应激综合征i的新疗法
JP2006545735A JP2007514788A (ja) 2003-12-17 2004-12-08 過敏性腸症候群の新規な処置ｉ
PCT/US2004/041005 WO2005060965A1 (en) 2003-12-17 2004-12-08 Novel treatment of irritable bowel syndrome i
EP04813335A EP1694326A1 (en) 2003-12-17 2004-12-08 Novel treatment of irritable bowel syndrome i

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303418A SE0303418D0 (sv) 2003-12-17 2003-12-17 New use 1

Publications (1)

Publication Number Publication Date
SE0303418D0 true SE0303418D0 (sv) 2003-12-17

Family

ID=30439731

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303418A SE0303418D0 (sv) 2003-12-17 2003-12-17 New use 1

Country Status (6)

Country Link
US (1) US20070203163A1 (sv)
EP (1) EP1694326A1 (sv)
JP (1) JP2007514788A (sv)
CN (1) CN1897943A (sv)
SE (1) SE0303418D0 (sv)
WO (1) WO2005060965A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022542863A (ja) 2019-07-24 2022-10-07 ハー・ルンドベック・アクチエゼルスカベット 抗ｍＧｌｕＲ５抗体及びその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1117403T3 (da) * 1998-10-02 2004-04-13 Sibia Neurosciences Inc MGLUR5-antagonister til behandling af smerte og angst
GB9821503D0 (en) * 1998-10-02 1998-11-25 Novartis Ag Organic compounds
GB0007193D0 (en) * 2000-03-25 2000-05-17 Univ Manchester Treatment of movrmrnt disorders
UA74419C2 (uk) * 2001-02-21 2005-12-15 Ен Пі Ес Фармасьютікалс, Інк. Заміщені піридини та їх застосування як антагоністів рецептору метаботропного глутамату
ATE465993T1 (de) * 2002-02-01 2010-05-15 Euro Celtique Sa 2-piperazinpyridine für die schmerzbehandlung
SE0201943D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New use
US7582635B2 (en) * 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain

Also Published As

Publication number Publication date
EP1694326A1 (en) 2006-08-30
WO2005060965A1 (en) 2005-07-07
JP2007514788A (ja) 2007-06-07
CN1897943A (zh) 2007-01-17
US20070203163A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
NO20051260L (no) Arylsubstituerte diazabicykloalkaner som nikotinacetylcholinagonister
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
DE602006007556D1 (de) Heteroarylsulfonylstilbene als 5-ht2a-antagonisten
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
BRPI0414592A (pt) antagonistas de receptores de trombina
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
ATE399770T1 (de) Tachykininrezeptorantagonisten
DE60214990D1 (de) Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten
ATE356623T1 (de) 5-ht3-rezeptorantagonisten und verwendungsverfahren
EA200700367A1 (ru) Новые производные 4-бензилиденпиперидина
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
EA200600688A1 (ru) Арилинденпиридины и арилинденпиримидины и их применение в качестве антагонистов аденозинового рецептора а2а
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
SE0303418D0 (sv) New use 1
NO20044473L (no) Ikke-steroidal progesteron reseptor modulatorer
NO20081529L (no) Naftyridinderivater
SE0303489D0 (sv) New use VII
SE0301794D0 (sv) New use III
SE0303419D0 (sv) New use 11
SE0303488D0 (sv) New use 1X
SE0403005D0 (sv) New use
SE0301795D0 (sv) New use I